Slovenian regulators slam Polydrug API plant in India

By Gareth Macdonald contact

- Last updated on GMT

Polydrug Labs site in Maharashtra, India
Polydrug Labs site in Maharashtra, India

Related tags: European union, Beta blocker

Polydrug Laboratories chose not to log customer complaints about APIs made at its plants in Maharashtra according to Slovenian regulators.

The agency for medicinal products and medical devices of the Republic of Slovenia (Jazmp) logged its concerns on the European Union’s Eudra GMP database last night​, explaining that they are based on an inspection conducted on March 18.

The regulators said its inspectors observed 17 breaches of current good manufacturing practices at the facility, five of which it described as ‘major’ including that customer complaints were “deliberately unregistered in the official logbook.”

Other transgressions included that access to quality records is not controlled and that Polydrug failed to “address risks of cross contamination for APIs sent out to micronisation subcontractor​” both of which pose a “potential risk for the patient​.”

The European Directorate for the Quality of Medicines & HealthCare (EDQM) has suspended certificates of suitability (CEP)​ for the seven active pharmaceutical ingredients (APIs) made at the three factories at the Polydrug site.

The affected APIs include the beta blockers metoprolol tartrate and metoprolol succinate, ferrous fumarate and the Pfizer-developed antifungal fluconazole, which is on the World Health Organisation’s (WHO) essential medicines list​.

Mumbai-headquartered Polydrug has yet to comment on the CEP suspension and all of the APIs involved were still listed as available on its website when this article was published.

The firm did not respond to a request for comment ahead of publication.

Related news

Show more

Related products

show more

Multiple Sclerosis Analytical Report

Multiple Sclerosis Analytical Report

PatSnap | 15-Jun-2022 | Technical / White Paper

More than 2.3 million people are living with MS worldwide. Although there is no cure, new research and innovative treatments are continuously emerging....

Flexible Filling Solution for CMOs

Flexible Filling Solution for CMOs

Single Use Support GmBH | 18-May-2022 | Insight Guide

Achieving flexibility requires modularity of technologies.

CMOs and CDMOs aspire to be flexible for multiple applications. Efficient automated...

Eastern & Western Manufacturing Solutions

Eastern & Western Manufacturing Solutions

Piramal Pharma Solutions | 15-Mar-2022 | Technical / White Paper

The best manufacturing site for a product can change throughout the life cycle. When bringing new drugs to market, biopharma companies may benefit from...

Related suppliers

Follow us


View more